Most insightful knowledge platform for professionals who wish to eradicate Antimicrobial resistance
Antimicrobial resistance (AMR) develops when bacteria, fungi, or viruses are exposed to antibiotics, antifungals, or antivirals. As a result, the antimicrobials become ineffective and infections may persist.
Mission of AMR Insights
Our mission is to inform, educate and connect professionals to make the world free from AMR.
What you can expect in 2019:
- Informing: Our professional E-newsletter
- Educating: Masterclass & courses on AMR
- Connecting: International matchmaking symposia (2)
Maarten van Dongen
Dr Maarten van Dongen studied Molecular and Medical Microbiology at the University of Groningen and obtained his PhD in Biochemistry at the University of Amsterdam. He has lead several large projects in the domain of AMR for various Dutch authorities. At the request of the Dutch Ministry of Health, Welfare and Sports VWS, he designed a national cooperation structure for the research and development of new antibiotics.
Symposium, preceding the PhD defense ceremony of Wouter Rottier
Conference is a platform for SMEs, start-ups, big pharma, academia, investors and authorities.
Gather leaders from pharmaceutical companies, academia and the wider scientific community together with regulatory agencies and public-private partnerships.
- QIAGEN partners with Ares Genetics to advance global fight against antibiotic-resistant pathogens 19 February, 2019 - QIAGEN N.V. announced a broad agreement with Ares Genetics, a subsidiary of Curetis N.V. , to develop innovative bioinformatics and assay solutions to accelerate research targeting the growing global health challenges posed by antibiotic-resistant bacteria.
- The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies 19 February, 2019 - Novel classes of molecules, such as engineered antibodies, antibiotic enhancers, siderophore conjugates, engineered phages, photo-switchable antibiotics, and genome editing facilitated by the CRISPR/Cas system, are providing new avenues to facilitate the development of antimicrobial therapies.
- Advocacy for the Antimicrobial Resistance (AMR) curricula among 19 February, 2019 - WHO Representative Dr. Syed Jaffar Hussain, Libyan Minister of Health, Dr. Ahmed Bin Omar and Director General of the National Center for Disease Control (NCDC) signed a National Plan of Action to Prevent and Contain Antibiotic Resistance in Libya. The document was signed on February 11, 2019 in Tripoli.